Seroatlas · Human Serome Atlas

RNASE7

Ribonuclease 7

Also known as: RAE1, RNAS7_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9H1E1
Gene
RNASE7
Ensembl
ENSG00000165799
Chromosome
14
Canonical length
156 aa
Protein class
Predicted secreted proteins
Secretome location
Secreted in other tissues

OverviewNCBI Gene

The protein encoded by this gene belongs to the pancreatic ribonuclease family, a subset of the ribonuclease A superfamily. The protein has broad-spectrum antimicrobial activity against bacteria and fungi. [provided by RefSeq, Oct 2014]

Canonical amino-acid sequenceUniProt

156 residues, UniProt reviewed canonical sequence.

>Q9H1E1|RNASE7
     1  MAPARAGFCP LLLLLLLGLW VAEIPVSAKP KGMTSSQWFK IQHMQPSPQA CNSAMKNINK
    61  HTKRCKDLNT FLHEPFSSVA ATCQTPKIAC KNGDKNCHQS HGAVSLTMCK LTSGKHPNCR
   121  YKEKRQNKSY VVACKPPQKK DSQQFHLVPV HLDRVL

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against RNASE7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Secreted
Secreted
Yes
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.36
Highest tissue expression
70 nTPM

Expression across tissuesHPA

Tissue

  • esophagus: 70 nTPM
  • skin: 26 nTPM
  • tonsil: 23 nTPM
  • cervix: 13 nTPM
  • vagina: 9.4 nTPM
  • gallbladder: 6.2 nTPM

Single-cell type

  • esophageal apical cells: 341 nCPM
  • epididymal basal cells: 44 nCPM
  • ocular epithelial cells: 38 nCPM
  • epididymal efferent duct ciliated cells: 22 nCPM
  • breast myoepithelial cells: 10 nCPM
  • syncytiotrophoblasts: 8.7 nCPM

Immune cell

  • basophil: 0 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM
  • gdT-cell: 0 nTPM
  • intermediate monocyte: 0 nTPM
  • MAIT T-cell: 0 nTPM

Brain region

  • basal ganglia: 0.2 nTPM
  • cerebral cortex: 0.2 nTPM
  • medulla oblongata: 0.2 nTPM
  • white matter: 0.2 nTPM
  • amygdala: 0.1 nTPM
  • cerebellum: 0.1 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.84
gnomAD pLI
0.12
gnomAD missense Z
0.43
DepMap mean gene effect
-0.01
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads RNASE7 as an antibody target. Whether an autoantibody or antibody against RNASE7 could matter depends on whether native RNASE7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

RNASE7 is annotated as secreted, so native RNASE7 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.

Annotation status

The present source text does not explicitly label RNASE7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/RNASE7. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...